Global Investor Forum Contact

Aart Jan van der Lelij

Prof. of clinical endocrinology at Erasmus MC, president of the European Society for Endocrinology and co-founder and scientific advisor of Alizé Pharma SAS.

11:30 - 12:45
Fighting Globesity

Moderator

Abstract

Fighting globesity
Researchers, medical professionals, policymakers, industrial actors, retailers and consumers are in the chain of responsibility of fighting ‘globesity’. In The Netherlands, 49,2 % of adults are overweight and 14,2 % are obese; of children under eighteen 13,6 % are overweight and 2,7 % are obese (RIVM, 2016).
Obesity is a strong predictor for developing type 2 diabetes. Obesity and diabetes type 2 are caused by genetic, medical and lifestyle factors, including unhealthy diet and lack of exercise. This panel session will tackle the problem from the perspective of personalized prevention and treatment, health economics and policy and public private collaboration.
Niels Chavannes
LUMC
Maarten van Dongen
LabForRent
Ingmar de Gooijer
myTomorrows
Mark van Houdenhoven
Sint Maartenskliniek

Henk van Houten
Philips

Arthur Lahr
Kiadis Pharma

Jos Malda
UMC Utrecht
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker

Madelon Maurice
UMC Utrecht

Tom Miller
GreyBird Ventures
Edwin Moses
Ablynx
Kees Recourt
Mibiton Foundation

Maurits van Selms
ACTA

Marianne van der Steen
MERLN
Markwin Velders
Kite Pharma
Werner Verbiest
Janssen Diagnostics
Eline Vrijland-van Beest
NightBalance
Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Gold sponsor
Partner
Partner
Award sponsor
Your logo?
© 2018 Innovation for Health